In 2022, the global artificial pancreas devices market was valued at USD 233.84 Million. It is projected to reach USD 1,093.9 Million by 2032, exhibiting a compound annual growth rate (CAGR) of 18.7% throughout the forecast period. The market's revenue growth is primarily fueled by the increasing prevalence of diabetes, a greater need for advanced diabetes treatment approaches, and advancements...